Cargando…
RNA-Based Multiplexing Assay for Routine Testing of Fusion and Splicing Variants in Cytological Samples of NSCLC Patients
The detection of ALK receptor tyrosine kinase (ALK), ROS proto-oncogen1, receptor tyrosine kinase (ROS1), ret proto-oncogen (RET), and MET proto-oncogen exon 14 skipping (METΔex14) allows for the selection of specific kinase inhibitor treatment in patients with non-small cell lung cancer (NSCLC). Mu...
Autores principales: | Aguado, Cristina, Giménez-Capitán, Ana, Román, Ruth, Rodríguez, Sonia, Jordana-Ariza, Núria, Aguilar, Andrés, Cabrera-Gálvez, Carlos, Rivas-Corredor, Carlos, Lianes, Pilar, Viteri, Santiago, Moya, Irene, Molina-Vila, Miguel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824402/ https://www.ncbi.nlm.nih.gov/pubmed/33374879 http://dx.doi.org/10.3390/diagnostics11010015 |
Ejemplares similares
-
Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients
por: Marin, Elba, et al.
Publicado: (2020) -
Detecting
ALK
,
ROS1, and
RET
fusions and the
METΔex14
splicing variant in liquid biopsies of non‐small‐cell lung cancer patients using RNA‐based techniques
por: Giménez‐Capitán, Ana, et al.
Publicado: (2023) -
Overcoming MET-mediated resistance in oncogene-driven NSCLC
por: Reischmann, Nadine, et al.
Publicado: (2023) -
Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer
por: Aguado, Cristina, et al.
Publicado: (2020) -
Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion
por: Aguado, Cristina, et al.
Publicado: (2018)